BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 63.34%
This Quarter Est. Return
1 Year Est. Return
+63.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.04B
AUM Growth
-$325M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
99
New
Increased
Reduced
Closed

Top Buys

1 +$64.1M
2 +$28.5M
3 +$24M
4
PCVX icon
Vaxcyte
PCVX
+$22.4M
5
CELC icon
Celcuity
CELC
+$16M

Top Sells

1 +$199M
2 +$26.6M
3 +$25.4M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$22.3M
5
AKRO icon
Akero Therapeutics
AKRO
+$22.2M

Sector Composition

1 Healthcare 98.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
1
BeOne Medicines Ltd
ONC
$35.3B
$2.39B 26.5%
8,799,053
-732,827
INCY icon
2
Incyte
INCY
$17.2B
$1.86B 20.6%
30,739,953
+487
ACAD icon
3
Acadia Pharmaceuticals
ACAD
$3.43B
$712M 7.88%
42,877,916
MDGL icon
4
Madrigal Pharmaceuticals
MDGL
$9.66B
$654M 7.24%
1,974,590
SMMT icon
5
Summit Therapeutics
SMMT
$16.8B
$471M 5.21%
24,424,865
INSM icon
6
Insmed
INSM
$34.6B
$410M 4.54%
5,380,626
+373,763
RYTM icon
7
Rhythm Pharmaceuticals
RYTM
$7.26B
$297M 3.29%
5,604,483
-479,766
RVMD icon
8
Revolution Medicines
RVMD
$9.26B
$281M 3.11%
7,936,972
KYMR icon
9
Kymera Therapeutics
KYMR
$4.17B
$164M 1.82%
5,995,929
ALKS icon
10
Alkermes
ALKS
$5.27B
$148M 1.64%
4,483,285
+301,534
EWTX icon
11
Edgewise Therapeutics
EWTX
$1.65B
$135M 1.5%
6,155,940
REPL icon
12
Replimune Group
REPL
$370M
$108M 1.19%
11,045,336
IMVT icon
13
Immunovant
IMVT
$3.13B
$93.3M 1.03%
5,457,881
+3,750,000
BCYC
14
Bicycle Therapeutics
BCYC
$581M
$92.4M 1.02%
10,885,357
IMCR icon
15
Immunocore
IMCR
$1.6B
$68.9M 0.76%
2,322,656
+807,338
KNSA icon
16
Kiniksa Pharmaceuticals
KNSA
$2.88B
$62.6M 0.69%
2,818,323
ABCL icon
17
AbCellera Biologics
ABCL
$1.82B
$61.4M 0.68%
27,525,640
RARE icon
18
Ultragenyx Pharmaceutical
RARE
$3.22B
$57.1M 0.63%
1,576,114
DNLI icon
19
Denali Therapeutics
DNLI
$2.38B
$50.7M 0.56%
3,731,695
KOD icon
20
Kodiak Sciences
KOD
$786M
$48.6M 0.54%
17,310,490
NRIX icon
21
Nurix Therapeutics
NRIX
$796M
$46.1M 0.51%
3,882,125
ARGX icon
22
argenx
ARGX
$50.1B
$46M 0.51%
77,760
-34,144
TRDA icon
23
Entrada Therapeutics
TRDA
$235M
$44M 0.49%
4,865,819
CELC icon
24
Celcuity
CELC
$1.96B
$43M 0.48%
4,257,735
+1,579,182
GRAL
25
GRAIL Inc
GRAL
$2.72B
$41.6M 0.46%
1,630,125